This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

11-Time Olympic Medalist Ryan Lochte Plunges Into Advocacy

Swimmer Travels to Capitol Hill to Urge Congress to  Continue Support of People with Duchenne Muscular Dystrophy  

WASHINGTON, Feb. 7, 2013 /PRNewswire-USNewswire/ --   Parent Project Muscular Dystrophy (PPMD), the leading non-profit in the United States focused entirely on Duchenne muscular dystrophy (Duchenne), welcomes 11-time Olympic medalist Ryan Lochte to their Annual Advocacy Conference in Washington, D.C., February 10-12, 2013. Lochte, one of the top American performers at the 2012 Olympic Games in London and a world record holder, is trading in his goggles and swim cap for a briefing binder and suit and tie to support families impacted by Duchenne.


Lochte, 28, has been a volunteer spokesman for PPMD since the 2008 Olympic Games in Beijing. Joining PPMD's fight to end Duchenne is more than just a good cause for him; Lochte's uncle, Ron Sweitzer, had a brother who died from the disease. In turn, Ryan has made ending Duchenne a priority.

To help achieve this goal, Lochte will return to Washington, D.C. with more than 100 advocates on February 11 th to urge Congress to reauthorize The Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013 (MD-CARE Act). The MD-CARE Act was first enacted in 2001 and reauthorized for a second time in 2008 when Lochte made his first trip to Capitol Hill to encourage congressional support.

This legislation has transformed life for many with the disease by intensifying muscular dystrophy research efforts and standardizing care; adding 10 years to the lifespan of Duchenne patients and spurring the development of potential therapies.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%
TSLA $222.56 -4.20%
YHOO $36.00 -0.03%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs